Sulphuric body odor under therapy with Brivaracetam

Seizure. 2018 Dec:63:91-92. doi: 10.1016/j.seizure.2018.10.006. Epub 2018 Oct 8.

Authors

Felix Zahnert¹, Katja Menzler¹, Susanne Knake²

Affiliations

¹ Epilepsy Center Hessen and Department of Neurology, Philipps-University Marburg, Marburg, Germany.
² Epilepsy Center Hessen and Department of Neurology, Philipps-University Marburg, Marburg, Germany. Electronic address: knake@med.uni-marburg.de.

PMID: 30468963
DOI: 10.1016/j.seizure.2018.10.006

No abstract available

Keywords: Adverse event; Brivaracetam; Monotherapy; Odour; Pharmacotherapy; Side effect.

Publication types

Case Reports
Letter

MeSH terms

Anticonvulsants / adverse effects*
Anticonvulsants / metabolism
Epilepsy / drug therapy*
Humans
Male
Middle Aged
Odorants*
Pyrrolidinones / adverse effects*
Pyrrolidinones / metabolism

Substances

Anticonvulsants
Pyrrolidinones
brivaracetam